Free Trial

147,238 Shares in UiPath Inc. (NYSE:PATH) Bought by RFG Advisory LLC

UiPath logo with Business Services background

RFG Advisory LLC purchased a new position in shares of UiPath Inc. (NYSE:PATH - Free Report) during the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 147,238 shares of the company's stock, valued at approximately $1,517,000.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the business. Norges Bank purchased a new stake in shares of UiPath in the 4th quarter valued at approximately $71,191,000. Senvest Management LLC grew its stake in shares of UiPath by 29.2% in the 4th quarter. Senvest Management LLC now owns 14,074,783 shares of the company's stock valued at $178,890,000 after buying an additional 3,180,300 shares during the period. AQR Capital Management LLC lifted its holdings in shares of UiPath by 45.3% in the 4th quarter. AQR Capital Management LLC now owns 6,646,320 shares of the company's stock worth $84,209,000 after acquiring an additional 2,072,089 shares during the last quarter. Jacobs Levy Equity Management Inc. lifted its holdings in shares of UiPath by 35.6% in the 4th quarter. Jacobs Levy Equity Management Inc. now owns 5,459,071 shares of the company's stock worth $69,385,000 after acquiring an additional 1,432,569 shares during the last quarter. Finally, Marshall Wace LLP lifted its holdings in shares of UiPath by 111.8% in the 4th quarter. Marshall Wace LLP now owns 2,456,102 shares of the company's stock worth $31,217,000 after acquiring an additional 1,296,382 shares during the last quarter. 62.50% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

PATH has been the topic of several recent analyst reports. UBS Group decreased their price objective on shares of UiPath from $14.00 to $10.00 and set a "sell" rating on the stock in a report on Thursday, March 13th. Wells Fargo & Company restated an "equal weight" rating on shares of UiPath in a report on Friday, May 30th. Mizuho decreased their price objective on shares of UiPath from $12.00 to $11.00 and set a "neutral" rating on the stock in a report on Tuesday, April 15th. Truist Financial upped their price objective on shares of UiPath from $12.00 to $13.00 and gave the stock a "hold" rating in a report on Friday, May 30th. Finally, Scotiabank upped their price objective on shares of UiPath from $12.00 to $13.00 and gave the stock a "sector perform" rating in a report on Friday, May 30th. Two research analysts have rated the stock with a sell rating, twelve have assigned a hold rating and two have issued a buy rating to the company's stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Hold" and a consensus price target of $13.83.

View Our Latest Analysis on PATH

UiPath Stock Performance

Shares of NYSE:PATH traded up $0.21 during trading hours on Thursday, reaching $13.26. The stock had a trading volume of 12,281,748 shares, compared to its average volume of 10,623,030. UiPath Inc. has a 1 year low of $9.38 and a 1 year high of $15.93. The firm's 50 day moving average is $11.65 and its 200-day moving average is $12.69. The stock has a market capitalization of $7.31 billion, a price-to-earnings ratio of -82.84 and a beta of 1.01.

UiPath (NYSE:PATH - Get Free Report) last announced its quarterly earnings data on Thursday, May 29th. The company reported $0.11 EPS for the quarter, beating analysts' consensus estimates of $0.10 by $0.01. UiPath had a negative net margin of 6.49% and a negative return on equity of 4.14%. The company had revenue of $356.62 million for the quarter, compared to the consensus estimate of $332.17 million. During the same period in the prior year, the firm posted $0.13 EPS. The company's quarterly revenue was up 6.4% compared to the same quarter last year. Analysts forecast that UiPath Inc. will post -0.17 EPS for the current year.

Insider Buying and Selling at UiPath

In related news, CFO Ashim Gupta sold 98,795 shares of the stock in a transaction on Thursday, May 1st. The shares were sold at an average price of $12.01, for a total value of $1,186,527.95. Following the transaction, the chief financial officer now directly owns 987,322 shares of the company's stock, valued at $11,857,737.22. This trade represents a 9.10% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CAO Hitesh Ramani sold 12,500 shares of the stock in a transaction on Thursday, April 3rd. The shares were sold at an average price of $10.19, for a total transaction of $127,375.00. Following the completion of the transaction, the chief accounting officer now directly owns 314,891 shares in the company, valued at $3,208,739.29. This trade represents a 3.82% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 23.19% of the company's stock.

UiPath Profile

(Free Report)

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.

See Also

Institutional Ownership by Quarter for UiPath (NYSE:PATH)

Should You Invest $1,000 in UiPath Right Now?

Before you consider UiPath, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UiPath wasn't on the list.

While UiPath currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Dirt-Cheap Stocks in a Market That’s Getting Expensive
Top 3 Defense Stocks to Profit From $175 Billion Golden Dome
Top 5 Stocks for June: AI Picks That Aren’t NVIDIA

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines